marketwatch
Biohaven’s stock surges as treatment slows progress of neurological disorder
MarketWatch • 12 MONTHS AGO
J.D. Vance warns of deliberate ‘bond-market death spiral’ if Trump is elected
MarketWatch • 12 MONTHS AGO
Palantir joins the S&P 500 today. Why an analyst is hitting pause on its stock.
MarketWatch • 12 MONTHS AGO
Microsoft’s stock hit with a rare downgrade. Why this analyst says stop buying.
MarketWatch • 12 MONTHS AGO
StandardAero sets terms for planned IPO at valuation of up to $7.5 billion
MarketWatch • 12 MONTHS AGO
Should Qualcomm take over Intel? Why Wall Street isn’t sold on a possible deal.
MarketWatch • 12 MONTHS AGO